ALLO vs CHD · rev $22.0K vs P/E 32, rev $6.11B
Allogene Therapeutics Inc (ALLO) versus Church & Dwight Company Inc (CHD) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Church & Dwight Company Inc (CHD) is a household & personal products company listed on NYSE.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported CHD revenue for 2024-12-31 was $6.11B. Net income was $585.3M. Revenue was up 4.1% from 2023-12-31 to 2024-12-31. CHD currently screens at market cap $23.08B and trailing P/E 32.0.
ALLO currently screens at market cap $258.1M. CHD currently screens at market cap $23.08B and trailing P/E 32.0.
Not investment advice. Open the ALLO and CHD stock pages for the full models.
Not investment advice.